• Four studies consistently demonstrate improvements when evaluating patellofemoral complications for ATTUNE® PS Knee patients.
• Improved patellofemoral outcomes, including less anterior knee pain for ATTUNE® PS Knee patients.
• As few as 2% of ATTUNE® Knee posterior stabilized patients experienced mild anterior pain.
• ATTUNE® Knee System has shown statistically significant improvements in PROMs compared to certain leading knee brands.
Working together, we can deliver innovative solutions to today's healthcare challenges to advance patient care and deliver clinical and economic value to health care systems throughout the world.
Johnson & Johnson Medical Devices Companies (JJMDC) advance patient care while delivering clinical and economic value to healthcare systems and helps providers address individual needs through a holistic approach.